165 related articles for article (PubMed ID: 18977144)
1. Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA.
Guggenheim ER; Ondrus AE; Movassaghi M; Lippard SJ
Bioorg Med Chem; 2008 Dec; 16(23):10121-8. PubMed ID: 18977144
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
Parsons JL; Dianova II; Allinson SL; Dianov GL
FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.
Guggenheim ER; Xu D; Zhang CX; Chang PV; Lippard SJ
Chembiochem; 2009 Jan; 10(1):141-57. PubMed ID: 19053130
[TBL] [Abstract][Full Text] [Related]
4. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
Zhu G; Chang P; Lippard SJ
Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
[TBL] [Abstract][Full Text] [Related]
5. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.
Wang B; Qian H; Yiu SM; Sun J; Zhu G
Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
[TBL] [Abstract][Full Text] [Related]
7. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
Wang Z; Qian H; Yiu SM; Sun J; Zhu G
J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
[TBL] [Abstract][Full Text] [Related]
8. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
Le TV; Suh JH; Kim N; Park HJ
Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors.
Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G
Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050
[TBL] [Abstract][Full Text] [Related]
10. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
11. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
12. Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.
Miknyoczki SJ; Jones-Bolin S; Pritchard S; Hunter K; Zhao H; Wan W; Ator M; Bihovsky R; Hudkins R; Chatterjee S; Klein-Szanto A; Dionne C; Ruggeri B
Mol Cancer Ther; 2003 Apr; 2(4):371-82. PubMed ID: 12700281
[TBL] [Abstract][Full Text] [Related]
13. Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.
Zhang CX; Chang PV; Lippard SJ
J Am Chem Soc; 2004 Jun; 126(21):6536-7. PubMed ID: 15161265
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
[TBL] [Abstract][Full Text] [Related]
16. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
17. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells.
Shino Y; Itoh Y; Kubota T; Yano T; Sendo T; Oishi R
Free Radic Biol Med; 2003 Oct; 35(8):966-77. PubMed ID: 14556861
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells.
Nguewa PA; Fuertes MA; Cepeda V; Alonso C; Quevedo C; Soto M; Pérez JM
Med Chem; 2006 Jan; 2(1):47-53. PubMed ID: 16787355
[TBL] [Abstract][Full Text] [Related]
20. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA.
Mendes F; Groessl M; Nazarov AA; Tsybin YO; Sava G; Santos I; Dyson PJ; Casini A
J Med Chem; 2011 Apr; 54(7):2196-206. PubMed ID: 21370912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]